'Procedural volume' presentation slideshows

Innovative Cancer Care Initiative #3 Transitioning to Risk - Episodes & Bundles

Innovative Cancer Care Initiative #3 Transitioning to Risk - Episodes & Bundles. Panelists . John Hennessy, M.B.A. Vice President Operations, Sarah Cannon Cancer Care Steven Peskin, M.D., M.B.A, F.A.C.P. Senior Medical Director, Horizon Blue Cross Clinical Innovation

714 views • 27 slides

Jonathan Fryer, MD, Jeff Fronza , MD, Jeff Wayne, MD,

457 views • 25 slides

JSB Market Research: Nuclear Medicine Market and Radiopharma

The market of radiopharmaceuticals is dominated by diagnostic radioisotopes, comprising of SPECT and PET radioisotopes. The lions share of the SPECT market is taken up by Tc-99m, whereas the PET market is dominated by F-18FDG isotope.

195 views • 7 slides